Cleared Traditional

K884464 - SPIROMETRICS MODEL 2200 SM200 FLOW SENSOR

K884464 is the FDA 510(k) clearance for SPIROMETRICS MODEL 2200 SM200 FLOW SENSOR by Spirometrics, Inc.. It is a Class 2 Anesthesiology device (product code JAX) cleared through the Traditional 510(k) pathway after a 87-day FDA review.

K884464 · Spirometrics, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1989
Decision
87d
Days
Class 2
Risk

K884464 is an FDA 510(k) clearance for the SPIROMETRICS MODEL 2200 SM200 FLOW SENSOR. Classified as Pneumotachometer (product code JAX), Class II - Special Controls.

Submitted by Spirometrics, Inc. (Auburn, US). The FDA issued a Cleared decision on January 19, 1989 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.2550 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Spirometrics, Inc. devices

Submission Details

510(k) Number K884464 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 24, 1988
Decision Date January 19, 1989
Days to Decision 87 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 140d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAX Pneumotachometer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.2550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.